- Location
treatment of overactive bladder
"-
AltheRx Pharmaceuticals Has Received a Notice of Allowance for Its Patent Application
Oct 21, 2013US-based clinical development firm AltheRx Pharmaceuticals has received a notice of allowance for its patent application from the US Patent and Trademark Office (USPTO) for the use of solabegron in combination with antimuscarinics at both ...
-
Watson Laboratories Received FDA Approval for Its ANDA of Trospium Chloride Capsules
Dec 4, 2012Watson Laboratories, a subsidiary of Watson Pharmaceuticals, has received FDA approval for its abbreviated new drug application (ANDA) of Trospium Chloride Extended-release Capsules. Watson anticipates beginning the shipment of the ...
Tags: FDA, Trospium Chloride Extended-release Capsules, pharmaceutical product
-
Mylan Have Signed a Settlement Agreement with Pfizer
Nov 29, 2012Mylan and its subsidiary, Mylan Pharmaceuticals, have signed a settlement agreement with Pfizer, Pharmacia & Upjohn Company and Pfizer Health related to Detrol LA patent litigation. The litigation is related to Mylan Pharmaceuticals' ...
-
Antares and Watson Pharmaceuticals Have Introduced Gelnique 3% Gel 3%
Nov 28, 2012Antares Pharma and Watson Pharmaceuticals have introduced Gelnique 3% (oxybutynin) gel 3%, for the treatment of overactive bladder (OAB). The product is available in a metered pump dispenser and is delivered transdermally, resulting in a ...
-
Myrbetriq Is a Once Daily Oral Beta-3 Adrenergic Agonist Discovered and Developed
Jun 4, 2012Astellas Pharma has gained FDA approval for Myrbetriq (mirabegron) extended-release tablets for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and urinary frequency. Myrbetriq is a once ...
Tags: FDA approval, pharmaceutical product, oral OAB treatment
-
Watson Pharmaceuticals Confirmed Favorable US District Court
Apr 5, 2012Watson Pharmaceuticals has confirmed favorable US District Court for the District of Delaware ruling in generic Sanctura XR (trospium chloride extended-release capsules) patent suit. The Court has ruled that the asserted claims of US ...
Tags: treatment of overactive bladder, pharmaceutical product
